FIELD: medicine.
SUBSTANCE: invention relates to oncology and immunology and is intended for diagnostics of risk of antitumor immune protection deficiency. Diagnostic technique for risk of antitumor immune protection deficiency includes determination of lymphocytes content CD25+, CD10+, CD71+, HLADR+ and cytokine IL-1β in peripheral venous blood, determination of concentration ratio of IL-1β to sum of absolute content of activated lymphocytes, CD25+, CD10+, CD71+, HLADR+, calculating of diagnostic index (DI): DI=1L-1β/Σ (CD25+CD10+CD71+HLADR+) and if DI is equal to 20.04 and more, than risk of antitumor immune protection deficiency is diagnosed.
EFFECT: diagnostic technique for risk of antitumor immune protection deficiency is disclosed.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING T-LYMPHOCYTE HYPERACTIVITY | 2012 |
|
RU2502998C1 |
| METHOD FOR PREDICTION OF LIFE EXPECTANCY IN PATIENTS WITH METASTATIC TUMORS | 2023 |
|
RU2821659C1 |
| METHOD OF EARLY MOLECULAR-BIOLOGICAL DIAGNOSIS OF MALIGNANT GROWTHS AND AMYOTROPHIC LATERAL SCLEROSIS | 2018 |
|
RU2706714C1 |
| METHOD FOR ONCOLOGICAL DISEASES COURSE PREDICTION | 2016 |
|
RU2622756C1 |
| METHOD FOR PREDICTING RISK OF MALIGNANT NEW GROWTHS | 2014 |
|
RU2552305C1 |
| METHOD FOR DETERMINING THERAPEUTIC APPROACH IN PATIENTS WITH METASTATIC FORMS AND RECURRENT TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2818730C1 |
| METHOD FOR ASSESSING THE SENSITIVITY OF A TUMOR TO IMMUNO-ONCOLOGICAL DRUGS | 2021 |
|
RU2771760C1 |
| METHOD OF UPDATING STAGE OF ADVANCED CERVICAL CANCER | 2015 |
|
RU2582979C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF III DEGREE AND PRE-INVASIVE CERVICAL CANCER, ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2012 |
|
RU2506892C1 |
| METHOD OF PREDICTING UNFAVOURABLE COURSE OF LOCALLY SPREAD FORMS OF HUMAN PAPILLOMA VIRUS-ASSOCIATED CERVICAL CANCER | 2012 |
|
RU2504326C1 |
